Header Logo

Oren Schaefer

Concepts (63)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonia
2
2005
291
0.210
Why?
Suppuration
1
2003
11
0.200
Why?
Mycobacterium avium Complex
1
2003
3
0.200
Why?
Mycobacterium avium-intracellulare Infection
1
2003
8
0.200
Why?
Respiratory Tract Infections
1
2003
90
0.190
Why?
Bacterial Infections
1
2003
153
0.180
Why?
Cough
1
2003
183
0.170
Why?
Complement C1 Inhibitor Protein
1
2010
1
0.080
Why?
Angioedemas, Hereditary
1
2010
1
0.080
Why?
Complement Inactivating Agents
1
2010
14
0.080
Why?
Severity of Illness Index
2
2005
1561
0.070
Why?
Mianserin
1
2005
3
0.060
Why?
Oxazolidinones
1
2005
15
0.060
Why?
Serotonin Syndrome
1
2005
9
0.060
Why?
Acetamides
1
2005
13
0.060
Why?
Citalopram
1
2005
21
0.060
Why?
Urticaria
1
2004
6
0.050
Why?
Antidepressive Agents
1
2005
226
0.050
Why?
Triage
1
2005
128
0.050
Why?
Hypothermia, Induced
1
2004
40
0.050
Why?
Cold Temperature
1
2004
51
0.050
Why?
Patient Admission
1
2005
198
0.050
Why?
Immunocompetence
1
2003
21
0.050
Why?
Bronchoscopy
1
2003
90
0.050
Why?
Intensive Care Units
1
2005
414
0.050
Why?
Aortic Valve
1
2004
190
0.050
Why?
Coronary Artery Bypass
1
2004
297
0.040
Why?
Heart Valve Prosthesis Implantation
1
2004
176
0.040
Why?
Radiography
1
2003
553
0.040
Why?
Diagnosis, Differential
1
2003
984
0.040
Why?
Chronic Disease
1
2003
756
0.040
Why?
Middle Aged
4
2005
17923
0.040
Why?
Anti-Bacterial Agents
1
2005
800
0.040
Why?
Female
5
2010
33382
0.030
Why?
Adult
3
2010
17133
0.030
Why?
Aged
3
2005
14664
0.020
Why?
Humans
6
2010
64279
0.020
Why?
Adolescent
1
2003
6305
0.020
Why?
Male
4
2010
30323
0.020
Why?
Retrospective Studies
1
2003
6742
0.020
Why?
Ultrafiltration
1
2010
11
0.020
Why?
Cross-Over Studies
1
2010
163
0.020
Why?
Infusions, Intravenous
1
2010
176
0.020
Why?
Nanotechnology
1
2010
135
0.020
Why?
Analysis of Variance
1
2010
608
0.020
Why?
Acute Disease
1
2010
672
0.020
Why?
Double-Blind Method
1
2010
744
0.020
Why?
Proportional Hazards Models
1
2010
735
0.020
Why?
Linezolid
1
2005
6
0.010
Why?
Protein Synthesis Inhibitors
1
2005
23
0.010
Why?
Drug Synergism
1
2005
142
0.010
Why?
Bone Marrow Transplantation
1
2005
140
0.010
Why?
Transplantation, Homologous
1
2005
249
0.010
Why?
Urinary Tract Infections
1
2005
93
0.010
Why?
Community-Acquired Infections
1
2005
94
0.010
Why?
Rewarming
1
2004
6
0.010
Why?
Leukemia, Myeloid, Acute
1
2005
192
0.010
Why?
Sensitivity and Specificity
1
2005
1164
0.010
Why?
Pilot Projects
1
2005
1020
0.010
Why?
Child
1
2010
4583
0.010
Why?
Risk Assessment
1
2005
2049
0.010
Why?
Aged, 80 and over
1
2005
5528
0.010
Why?
United States
1
2005
7923
0.010
Why?
Schaefer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_